| 5.1 Short-term visual acuity from 20/20 to 20/40 |
3 |
303 |
Odds Ratio(M-H, Fixed, 95% CI) |
1.65[0.91, 2.99] |
| 5.2 Time to resolution of primary hemorrhage (days) |
5 |
|
Other data |
No numeric data |
| 5.3 Risk of secondary hemorrhage |
5 |
578 |
Odds Ratio(M-H, Fixed, 95% CI) |
0.25[0.13, 0.49] |
| 5.4 Time to rebleed (days) |
5 |
|
Other data |
No numeric data |
| 5.5 Risk of corneal bloodstain |
2 |
|
Odds Ratio(M-H, Fixed, 95% CI) |
No totals |
| 5.6 Risk of glaucoma or elevated IOP |
4 |
543 |
Odds Ratio(M-H, Fixed, 95% CI) |
1.23[0.70, 2.16] |
| 5.7 Risk of optic atrophy |
1 |
|
Odds Ratio(M-H, Fixed, 95% CI) |
No totals |
| 5.8 Adverse effects: Nausea or vomiting |
2 |
|
Odds Ratio(M-H, Fixed, 95% CI) |
No totals |
| 5.9 Duration of hospitalization (days) |
3 |
|
Other data |
No numeric data |